Evidence map›Paper›PMID 41734386›Full record

ArticleBlood advances2026

Exposure to Agent Orange and association with myelodysplastic syndromes.

Mikkael A Sekeres, Amy E DeZern, Michael Otterstatter, Eric Padron, Tareq Al Baghdadi, James M Foran, Rami S Komrokji, Gregory A Abel, Wael Saber, Steven D Gore and 8 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Mikkael A SekeresDivision of Hematology, Sylvester Cancer Center, University of Miami, Miami, FL.ORCID 0000-0003-2009-6524
Amy E DeZernSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD.
Michael OtterstatterThe Emmes Company, Rockville, MD.ORCID 0000-0001-5489-014X
Eric PadronDepartment of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
Tareq Al BaghdadiTrinity Health, Ann Arbor, MI.
James M ForanDivision of Hematology & Medical Oncology, Mayo Clinic, Jacksonville, FL.
Rami S KomrokjiDepartment of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.ORCID 0000-0002-1876-5269
Gregory A AbelDivision of Population Sciences, Dana-Farber Cancer Institute, Boston, MA.
Wael SaberDivision of Hematology/Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.
Steven D GoreCancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD.
Cecilia LeeDivision of Cancer Prevention, National Cancer Institute, Rockville, MD.
Rafael BejarDivision of Hematology and Cellular Therapy, University of California San Diego, San Diego, CA.ORCID 0000-0002-5603-4598
Jane J LiuIllinois Cancer Care, Peoria, IL.
H Joachim DeegClinical Research Division, University of Washington and Fred Hutchinson Cancer Center, Seattle, WA.ORCID 0000-0002-4426-9023
Seth ShermanThe Emmes Company, Rockville, MD.ORCID 0000-0003-3667-9898
R Coleman LindsleyDivision of Population Sciences, Dana-Farber Cancer Institute, Boston, MA.ORCID 0000-0001-9822-806X
Matthew J WalterDepartment of Medicine, Division of Oncology, Washington University, St. Louis, MO.
Nancy GillisDepartment of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.ORCID 0000-0002-7744-8490

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41734386
PMCPMC13141501

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.